Powder: -20°C for 3 years | In solvent: -80°C for 1 year
FH1 (NSC-12407) 可提高肝细胞功能,促进诱导多能干 (iPS) 衍生的肝细胞向更成熟的表型分化,并促使分化良好的肝细胞样细胞 (iHeps) 培养物的成熟。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
5 mg | ¥ 255 | 现货 | ||
10 mg | ¥ 415 | 现货 | ||
25 mg | ¥ 852 | 现货 | ||
50 mg | ¥ 1,497 | 现货 | ||
100 mg | ¥ 2,683 | 现货 | ||
200 mg | ¥ 3,675 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 456 | 现货 |
产品描述 | FH1 (NSC-12407) (BRD-K4477), a small molecule, enhances the functions of hepatocytes and promotes differentiation hepatocytes derived by iPS. |
体内活性 | 在肝细胞中,FH1(BRD-K4477)促进分化完整的iHeps成熟,增强细胞功能。 |
激酶实验 | Affinity determination: Binding affinities (Ki or IC50) of ABT-263 against different isoforms of Bcl-2 family are determined with competitive fluorescence polarization assays. The following peptide probe/protein pairs are used: f-bad (1 nM) and Bcl-xL (6 nM), f-Bax (1 nM) and Bcl-2 (10 nM), f-Bax (1 nM) and Bcl-w (40 nM), f-Noxa (2 nM) and Mcl-1 (40 nM), and f-Bax (1 nM) and Bcl-2-A1 (15 nM). Binding affinities for Bcl-xL are also determined using a time-resolved fluorescence resonance energy transfer assay. Bcl-xL (1 nM, His tagged) is mixed with 200 nM f-Bak, 1 nM Tb-labeled anti-His antibody, and ABT-263 at room temperature for 30 min. Fluorescence is measured on an Envision plate reader using a 340/35 nm excitation filter and 520/525 (f-Bak) and 495/510 nm (Tb-labeled anti-His antibody) emission filters. |
别名 | BRD-K4477, NSC 12407 |
分子量 | 282.34 |
分子式 | C17H18N2O2 |
CAS No. | 2719-05-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: < 1 mg/mL (insoluble or slightly soluble)
DMSO: 4.62 mg/mL (16.35 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 3.5418 mL | 17.7091 mL | 35.4183 mL | 88.5457 mL |
5 mM | 0.7084 mL | 3.5418 mL | 7.0837 mL | 17.7091 mL | |
10 mM | 0.3542 mL | 1.7709 mL | 3.5418 mL | 8.8546 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
FH1 2719-05-3 Others hHNF4α IPS hALB FH-1 iPSC BRD-K-4477 BRD-K 4477 FH 1 inhibit Inhibitor hNTCP BRD-K4477 hRXR NSC 12407 NSC12407 NSC-12407 inhibitor